Recombinant Protein Drug Market Report

Japan Recombinant Protein Drug Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major Region

  • POSTDATE：Sep 16, 2019
  • PAGES：203
  • REPORT CODE：GMM270992
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Recombinant Protein Drug market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Recombinant Protein Drug market. Detailed analysis of key players, along with key growth strategies adopted by Recombinant Protein Drug industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.


    By Player:

    • Ortho Biotech

    • Merck Serono

    • SL PHARM

    • Sanofi

    • Amgen

    • NCPC

    • Livzon Pharmaceutical

    • Shenzhen Neptunus Interlong Bio-Technique

    • Abcam

    • Heng Rui

    • GenSci

    • Novo Nordisk

    • Eli Lilly

    • Kyowa Hakko Kirin

    • Anhui Anke Biotechnology

    • Pharmingen

    • Changchun High & New Technology Industry

    • Roche


    By Type:

    • Recombinant Insulin

    • Recombinant Human Interferon (rhIFN)

    • Recombinant Human Erythropoietin (rhEPO)

    • Recombinant Human Granulocyte Colony-stimulating Factor (rhG-CSF)

    • Recombinant Human Growth Hormone (rhGH)

    • Recombinant Human Follicle-stimulating Hormone (rhFSH)

    • Others


    By End-User:

    • Hospital use

    • Clinic use

    • Household


    By Region:

    • Hokkaido

    • Tohoku

    • Kanto

    • Chubu

    • Kinki

    • Chugoku

    • Shikoku

    • Kyushu

  • 1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Recombinant Protein Drug Market

    • 1.3 Market Segment by Type

      • 1.3.1 Japan Recombinant Protein Drug Market Size and Growth Rate of Recombinant Insulin from 2014 to 2026

      • 1.3.2 Japan Recombinant Protein Drug Market Size and Growth Rate of Recombinant Human Interferon (rhIFN) from 2014 to 2026

      • 1.3.3 Japan Recombinant Protein Drug Market Size and Growth Rate of Recombinant Human Erythropoietin (rhEPO) from 2014 to 2026

      • 1.3.4 Japan Recombinant Protein Drug Market Size and Growth Rate of Recombinant Human Granulocyte Colony-stimulating Factor (rhG-CSF) from 2014 to 2026

      • 1.3.5 Japan Recombinant Protein Drug Market Size and Growth Rate of Recombinant Human Growth Hormone (rhGH) from 2014 to 2026

      • 1.3.6 Japan Recombinant Protein Drug Market Size and Growth Rate of Recombinant Human Follicle-stimulating Hormone (rhFSH) from 2014 to 2026

      • 1.3.7 Japan Recombinant Protein Drug Market Size and Growth Rate of Others from 2014 to 2026

    • 1.4 Market Segment by Application

      • 1.4.1 Japan Recombinant Protein Drug Market Size and Growth Rate of Hospital use from 2014 to 2026

      • 1.4.2 Japan Recombinant Protein Drug Market Size and Growth Rate of Clinic use from 2014 to 2026

      • 1.4.3 Japan Recombinant Protein Drug Market Size and Growth Rate of Household from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Hokkaido Recombinant Protein Drug Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Tohoku Recombinant Protein Drug Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Kanto Recombinant Protein Drug Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Chubu Recombinant Protein Drug Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Kinki Recombinant Protein Drug Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Chugoku Recombinant Protein Drug Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Shikoku Recombinant Protein Drug Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Kyushu Recombinant Protein Drug Consumption Market Size and Growth Rate from 2014 to 2026


    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants


    3 Segmentation of Recombinant Protein Drug Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Recombinant Protein Drug by Major Types

      • 3.4.1 Market Size and Growth Rate of Recombinant Insulin

      • 3.4.2 Market Size and Growth Rate of Recombinant Human Interferon (rhIFN)

      • 3.4.3 Market Size and Growth Rate of Recombinant Human Erythropoietin (rhEPO)

      • 3.4.4 Market Size and Growth Rate of Recombinant Human Granulocyte Colony-stimulating Factor (rhG-CSF)

      • 3.4.5 Market Size and Growth Rate of Recombinant Human Growth Hormone (rhGH)

      • 3.4.6 Market Size and Growth Rate of Recombinant Human Follicle-stimulating Hormone (rhFSH)

      • 3.4.7 Market Size and Growth Rate of Others

    4 Segmentation of Recombinant Protein Drug Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Recombinant Protein Drug by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Recombinant Protein Drug in Hospital use

      • 4.4.2 Market Size and Growth Rate of Recombinant Protein Drug in Clinic use

      • 4.4.3 Market Size and Growth Rate of Recombinant Protein Drug in Household


    5 Market Analysis by Regions

    • 5.1 Japan Recombinant Protein Drug Production Analysis by Regions

    • 5.2 Japan Recombinant Protein Drug Consumption Analysis by Regions


    6 Hokkaido Recombinant Protein Drug Landscape Analysis

    • 6.1 Hokkaido Recombinant Protein Drug Landscape Analysis by Major Types

    • 6.2 Hokkaido Recombinant Protein Drug Landscape Analysis by Major End-Users


    7 Tohoku Recombinant Protein Drug Landscape Analysis

    • 7.1 Tohoku Recombinant Protein Drug Landscape Analysis by Major Types

    • 7.2 Tohoku Recombinant Protein Drug Landscape Analysis by Major End-Users


    8 Kanto Recombinant Protein Drug Landscape Analysis

    • 8.1 Kanto Recombinant Protein Drug Landscape Analysis by Major Types

    • 8.2 Kanto Recombinant Protein Drug Landscape Analysis by Major End-Users


    9 Chubu Recombinant Protein Drug Landscape Analysis

    • 9.1 Chubu Recombinant Protein Drug Landscape Analysis by Major Types

    • 9.2 Chubu Recombinant Protein Drug Landscape Analysis by Major End-Users


    10 Kinki Recombinant Protein Drug Landscape Analysis

    • 10.1 Kinki Recombinant Protein Drug Landscape Analysis by Major Types

    • 10.2 Kinki Recombinant Protein Drug Landscape Analysis by Major End-Users


    11 Chugoku Recombinant Protein Drug Landscape Analysis

    • 11.1 Chugoku Recombinant Protein Drug Landscape Analysis by Major Types

    • 11.2 Chugoku Recombinant Protein Drug Landscape Analysis by Major End-Users


    12 Shikoku Recombinant Protein Drug Landscape Analysis

    • 12.1 Shikoku Recombinant Protein Drug Landscape Analysis by Major Types

    • 12.2 Shikoku Recombinant Protein Drug Landscape Analysis by Major End-Users


    13 Kyushu Recombinant Protein Drug Landscape Analysis

    • 13.1 Kyushu Recombinant Protein Drug Landscape Analysis by Major Types

    • 13.2 Kyushu Recombinant Protein Drug Landscape Analysis by Major End-Users


    14 Major Players Profiles

    • 14.1 Ortho Biotech

      • 14.1.1 Ortho Biotech Company Profile and Recent Development

      • 14.1.2 Market Performance

      • 14.1.3 Product and Service Introduction

    • 14.2 Merck Serono

      • 14.2.1 Merck Serono Company Profile and Recent Development

      • 14.2.2 Market Performance

      • 14.2.3 Product and Service Introduction

    • 14.3 SL PHARM

      • 14.3.1 SL PHARM Company Profile and Recent Development

      • 14.3.2 Market Performance

      • 14.3.3 Product and Service Introduction

    • 14.4 Sanofi

      • 14.4.1 Sanofi Company Profile and Recent Development

      • 14.4.2 Market Performance

      • 14.4.3 Product and Service Introduction

    • 14.5 Amgen

      • 14.5.1 Amgen Company Profile and Recent Development

      • 14.5.2 Market Performance

      • 14.5.3 Product and Service Introduction

    • 14.6 NCPC

      • 14.6.1 NCPC Company Profile and Recent Development

      • 14.6.2 Market Performance

      • 14.6.3 Product and Service Introduction

    • 14.7 Livzon Pharmaceutical

      • 14.7.1 Livzon Pharmaceutical Company Profile and Recent Development

      • 14.7.2 Market Performance

      • 14.7.3 Product and Service Introduction

    • 14.8 Shenzhen Neptunus Interlong Bio-Technique

      • 14.8.1 Shenzhen Neptunus Interlong Bio-Technique Company Profile and Recent Development

      • 14.8.2 Market Performance

      • 14.8.3 Product and Service Introduction

    • 14.9 Abcam

      • 14.9.1 Abcam Company Profile and Recent Development

      • 14.9.2 Market Performance

      • 14.9.3 Product and Service Introduction

    • 14.10 Heng Rui

      • 14.10.1 Heng Rui Company Profile and Recent Development

      • 14.10.2 Market Performance

      • 14.10.3 Product and Service Introduction

    • 14.11 GenSci

      • 14.11.1 GenSci Company Profile and Recent Development

      • 14.11.2 Market Performance

      • 14.11.3 Product and Service Introduction

    • 14.12 Novo Nordisk

      • 14.12.1 Novo Nordisk Company Profile and Recent Development

      • 14.12.2 Market Performance

      • 14.12.3 Product and Service Introduction

    • 14.13 Eli Lilly

      • 14.13.1 Eli Lilly Company Profile and Recent Development

      • 14.13.2 Market Performance

      • 14.13.3 Product and Service Introduction

    • 14.14 Kyowa Hakko Kirin

      • 14.14.1 Kyowa Hakko Kirin Company Profile and Recent Development

      • 14.14.2 Market Performance

      • 14.14.3 Product and Service Introduction

    • 14.15 Anhui Anke Biotechnology

      • 14.15.1 Anhui Anke Biotechnology Company Profile and Recent Development

      • 14.15.2 Market Performance

      • 14.15.3 Product and Service Introduction

    • 14.16 Pharmingen

      • 14.16.1 Pharmingen Company Profile and Recent Development

      • 14.16.2 Market Performance

      • 14.16.3 Product and Service Introduction

    • 14.17 Changchun High & New Technology Industry

      • 14.17.1 Changchun High & New Technology Industry Company Profile and Recent Development

      • 14.17.2 Market Performance

      • 14.17.3 Product and Service Introduction

    • 14.18 Roche

      • 14.18.1 Roche Company Profile and Recent Development

      • 14.18.2 Market Performance

      • 14.18.3 Product and Service Introduction

     

    The List of Tables and Figures (Totals 120 Figures and 150 Tables)

     

    • Figure Japan Recombinant Protein Drug Market Size and Growth Rate of Recombinant Insulin from 2014 to 2026

    • Figure Japan Recombinant Protein Drug Market Size and Growth Rate of Recombinant Human Interferon (rhIFN) from 2014 to 2026

    • Figure Japan Recombinant Protein Drug Market Size and Growth Rate of Recombinant Human Erythropoietin (rhEPO) from 2014 to 2026

    • Figure Japan Recombinant Protein Drug Market Size and Growth Rate of Recombinant Human Granulocyte Colony-stimulating Factor (rhG-CSF) from 2014 to 2026

    • Figure Japan Recombinant Protein Drug Market Size and Growth Rate of Recombinant Human Growth Hormone (rhGH) from 2014 to 2026

    • Figure Japan Recombinant Protein Drug Market Size and Growth Rate of Recombinant Human Follicle-stimulating Hormone (rhFSH) from 2014 to 2026

    • Figure Japan Recombinant Protein Drug Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Japan Recombinant Protein Drug Market Size and Growth Rate of Hospital use from 2014 to 2026

    • Figure Japan Recombinant Protein Drug Market Size and Growth Rate of Clinic use from 2014 to 2026

    • Figure Japan Recombinant Protein Drug Market Size and Growth Rate of Household from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure Hokkaido Recombinant Protein Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Tohoku Recombinant Protein Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kanto Recombinant Protein Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chubu Recombinant Protein Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kinki Recombinant Protein Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chugoku Recombinant Protein Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Shikoku Recombinant Protein Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kyushu Recombinant Protein Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Recombinant Protein Drug Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Recombinant Protein Drug

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Recombinant Protein Drug by Different Types from 2014 to 2026

    • Table Consumption Share of Recombinant Protein Drug by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Recombinant Insulin

    • Figure Market Size and Growth Rate of Recombinant Human Interferon (rhIFN)

    • Figure Market Size and Growth Rate of Recombinant Human Erythropoietin (rhEPO)

    • Figure Market Size and Growth Rate of Recombinant Human Granulocyte Colony-stimulating Factor (rhG-CSF)

    • Figure Market Size and Growth Rate of Recombinant Human Growth Hormone (rhGH)

    • Figure Market Size and Growth Rate of Recombinant Human Follicle-stimulating Hormone (rhFSH)

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Recombinant Protein Drug by Different End-Users from 2014 to 2026

    • Table Consumption Share of Recombinant Protein Drug by Different End-Users from 2014 to 2026

    • Figure Japan Recombinant Protein Drug Market Size and Growth Rate of Hospital use from 2014 to 2026

    • Figure Japan Recombinant Protein Drug Market Size and Growth Rate of Clinic use from 2014 to 2026

    • Figure Japan Recombinant Protein Drug Market Size and Growth Rate of Household from 2014 to 2026

    • Table Japan Recombinant Protein Drug Production by Regions

    • Table Japan Recombinant Protein Drug Production Share by Regions

    • Figure Japan Recombinant Protein Drug Production Share by Regions in 2014

    • Figure Japan Recombinant Protein Drug Production Share by Regions in 2018

    • Figure Japan Recombinant Protein Drug Production Share by Regions in 2026

    • Table Japan Recombinant Protein Drug Consumption by Regions

    • Table Japan Recombinant Protein Drug Consumption Share by Regions

    • Figure Japan Recombinant Protein Drug Consumption Share by Regions in 2014

    • Figure Japan Recombinant Protein Drug Consumption Share by Regions in 2018

    • Figure Japan Recombinant Protein Drug Consumption Share by Regions in 2026

    • Table Hokkaido Recombinant Protein Drug Consumption by Types from 2014 to 2026

    • Table Hokkaido Recombinant Protein Drug Consumption Share by Types from 2014 to 2026

    • Figure Hokkaido Recombinant Protein Drug Consumption Share by Types in 2014

    • Figure Hokkaido Recombinant Protein Drug Consumption Share by Types in 2018

    • Figure Hokkaido Recombinant Protein Drug Consumption Share by Types in 2026

    • Table Hokkaido Recombinant Protein Drug Consumption by End-Users from 2014 to 2026

    • Table Hokkaido Recombinant Protein Drug Consumption Share by End-Users from 2014 to 2026

    • Figure Hokkaido Recombinant Protein Drug Consumption Share by End-Users in 2014

    • Figure Hokkaido Recombinant Protein Drug Consumption Share by End-Users in 2018

    • Figure Hokkaido Recombinant Protein Drug Consumption Share by End-Users in 2026

    • Table Tohoku Recombinant Protein Drug Consumption by Types from 2014 to 2026

    • Table Tohoku Recombinant Protein Drug Consumption Share by Types from 2014 to 2026

    • Figure Tohoku Recombinant Protein Drug Consumption Share by Types in 2014

    • Figure Tohoku Recombinant Protein Drug Consumption Share by Types in 2018

    • Figure Tohoku Recombinant Protein Drug Consumption Share by Types in 2026

    • Table Tohoku Recombinant Protein Drug Consumption by End-Users from 2014 to 2026

    • Table Tohoku Recombinant Protein Drug Consumption Share by End-Users from 2014 to 2026

    • Figure Tohoku Recombinant Protein Drug Consumption Share by End-Users in 2014

    • Figure Tohoku Recombinant Protein Drug Consumption Share by End-Users in 2018

    • Figure Tohoku Recombinant Protein Drug Consumption Share by End-Users in 2026

    • Table Kanto Recombinant Protein Drug Consumption by Types from 2014 to 2026

    • Table Kanto Recombinant Protein Drug Consumption Share by Types from 2014 to 2026

    • Figure Kanto Recombinant Protein Drug Consumption Share by Types in 2014

    • Figure Kanto Recombinant Protein Drug Consumption Share by Types in 2018

    • Figure Kanto Recombinant Protein Drug Consumption Share by Types in 2026

    • Table Kanto Recombinant Protein Drug Consumption by End-Users from 2014 to 2026

    • Table Kanto Recombinant Protein Drug Consumption Share by End-Users from 2014 to 2026

    • Figure Kanto Recombinant Protein Drug Consumption Share by End-Users in 2014

    • Figure Kanto Recombinant Protein Drug Consumption Share by End-Users in 2018

    • Figure Kanto Recombinant Protein Drug Consumption Share by End-Users in 2026

    • Table Chubu Recombinant Protein Drug Consumption by Types from 2014 to 2026

    • Table Chubu Recombinant Protein Drug Consumption Share by Types from 2014 to 2026

    • Figure Chubu Recombinant Protein Drug Consumption Share by Types in 2014

    • Figure Chubu Recombinant Protein Drug Consumption Share by Types in 2018

    • Figure Chubu Recombinant Protein Drug Consumption Share by Types in 2026

    • Table Chubu Recombinant Protein Drug Consumption by End-Users from 2014 to 2026

    • Table Chubu Recombinant Protein Drug Consumption Share by End-Users from 2014 to 2026

    • Figure Chubu Recombinant Protein Drug Consumption Share by End-Users in 2014

    • Figure Chubu Recombinant Protein Drug Consumption Share by End-Users in 2018

    • Figure Chubu Recombinant Protein Drug Consumption Share by End-Users in 2026

    • Table Kinki Recombinant Protein Drug Consumption by Types from 2014 to 2026

    • Table Kinki Recombinant Protein Drug Consumption Share by Types from 2014 to 2026

    • Figure Kinki Recombinant Protein Drug Consumption Share by Types in 2014

    • Figure Kinki Recombinant Protein Drug Consumption Share by Types in 2018

    • Figure Kinki Recombinant Protein Drug Consumption Share by Types in 2026

    • Table Kinki Recombinant Protein Drug Consumption by End-Users from 2014 to 2026

    • Table Kinki Recombinant Protein Drug Consumption Share by End-Users from 2014 to 2026

    • Figure Kinki Recombinant Protein Drug Consumption Share by End-Users in 2014

    • Figure Kinki Recombinant Protein Drug Consumption Share by End-Users in 2018

    • Figure Kinki Recombinant Protein Drug Consumption Share by End-Users in 2026

    • Table Chugoku Recombinant Protein Drug Consumption by Types from 2014 to 2026

    • Table Chugoku Recombinant Protein Drug Consumption Share by Types from 2014 to 2026

    • Figure Chugoku Recombinant Protein Drug Consumption Share by Types in 2014

    • Figure Chugoku Recombinant Protein Drug Consumption Share by Types in 2018

    • Figure Chugoku Recombinant Protein Drug Consumption Share by Types in 2026

    • Table Chugoku Recombinant Protein Drug Consumption by End-Users from 2014 to 2026

    • Table Chugoku Recombinant Protein Drug Consumption Share by End-Users from 2014 to 2026

    • Figure Chugoku Recombinant Protein Drug Consumption Share by End-Users in 2014

    • Figure Chugoku Recombinant Protein Drug Consumption Share by End-Users in 2018

    • Figure Chugoku Recombinant Protein Drug Consumption Share by End-Users in 2026

    • Table Shikoku Recombinant Protein Drug Consumption by Types from 2014 to 2026

    • Table Shikoku Recombinant Protein Drug Consumption Share by Types from 2014 to 2026

    • Figure Shikoku Recombinant Protein Drug Consumption Share by Types in 2014

    • Figure Shikoku Recombinant Protein Drug Consumption Share by Types in 2018

    • Figure Shikoku Recombinant Protein Drug Consumption Share by Types in 2026

    • Table Shikoku Recombinant Protein Drug Consumption by End-Users from 2014 to 2026

    • Table Shikoku Recombinant Protein Drug Consumption Share by End-Users from 2014 to 2026

    • Figure Shikoku Recombinant Protein Drug Consumption Share by End-Users in 2014

    • Figure Shikoku Recombinant Protein Drug Consumption Share by End-Users in 2018

    • Figure Shikoku Recombinant Protein Drug Consumption Share by End-Users in 2026

    • Table Kyushu Recombinant Protein Drug Consumption by Types from 2014 to 2026

    • Table Kyushu Recombinant Protein Drug Consumption Share by Types from 2014 to 2026

    • Figure Kyushu Recombinant Protein Drug Consumption Share by Types in 2014

    • Figure Kyushu Recombinant Protein Drug Consumption Share by Types in 2018

    • Figure Kyushu Recombinant Protein Drug Consumption Share by Types in 2026

    • Table Kyushu Recombinant Protein Drug Consumption by End-Users from 2014 to 2026

    • Table Kyushu Recombinant Protein Drug Consumption Share by End-Users from 2014 to 2026

    • Figure Kyushu Recombinant Protein Drug Consumption Share by End-Users in 2014

    • Figure Kyushu Recombinant Protein Drug Consumption Share by End-Users in 2018

    • Figure Kyushu Recombinant Protein Drug Consumption Share by End-Users in 2026

    • Table Company Profile and Development Status of Ortho Biotech

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ortho Biotech

    • Figure Sales and Growth Rate Analysis of Ortho Biotech

    • Figure Revenue and Market Share Analysis of Ortho Biotech

    • Table Product and Service Introduction of Ortho Biotech

    • Table Company Profile and Development Status of Merck Serono

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck Serono

    • Figure Sales and Growth Rate Analysis of Merck Serono

    • Figure Revenue and Market Share Analysis of Merck Serono

    • Table Product and Service Introduction of Merck Serono

    • Table Company Profile and Development Status of SL PHARM

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of SL PHARM

    • Figure Sales and Growth Rate Analysis of SL PHARM

    • Figure Revenue and Market Share Analysis of SL PHARM

    • Table Product and Service Introduction of SL PHARM

    • Table Company Profile and Development Status of Sanofi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi

    • Figure Sales and Growth Rate Analysis of Sanofi

    • Figure Revenue and Market Share Analysis of Sanofi

    • Table Product and Service Introduction of Sanofi

    • Table Company Profile and Development Status of Amgen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen

    • Figure Sales and Growth Rate Analysis of Amgen

    • Figure Revenue and Market Share Analysis of Amgen

    • Table Product and Service Introduction of Amgen

    • Table Company Profile and Development Status of NCPC

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of NCPC

    • Figure Sales and Growth Rate Analysis of NCPC

    • Figure Revenue and Market Share Analysis of NCPC

    • Table Product and Service Introduction of NCPC

    • Table Company Profile and Development Status of Livzon Pharmaceutical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Livzon Pharmaceutical

    • Figure Sales and Growth Rate Analysis of Livzon Pharmaceutical

    • Figure Revenue and Market Share Analysis of Livzon Pharmaceutical

    • Table Product and Service Introduction of Livzon Pharmaceutical

    • Table Company Profile and Development Status of Shenzhen Neptunus Interlong Bio-Technique

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shenzhen Neptunus Interlong Bio-Technique

    • Figure Sales and Growth Rate Analysis of Shenzhen Neptunus Interlong Bio-Technique

    • Figure Revenue and Market Share Analysis of Shenzhen Neptunus Interlong Bio-Technique

    • Table Product and Service Introduction of Shenzhen Neptunus Interlong Bio-Technique

    • Table Company Profile and Development Status of Abcam

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abcam

    • Figure Sales and Growth Rate Analysis of Abcam

    • Figure Revenue and Market Share Analysis of Abcam

    • Table Product and Service Introduction of Abcam

    • Table Company Profile and Development Status of Heng Rui

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Heng Rui

    • Figure Sales and Growth Rate Analysis of Heng Rui

    • Figure Revenue and Market Share Analysis of Heng Rui

    • Table Product and Service Introduction of Heng Rui

    • Table Company Profile and Development Status of GenSci

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GenSci

    • Figure Sales and Growth Rate Analysis of GenSci

    • Figure Revenue and Market Share Analysis of GenSci

    • Table Product and Service Introduction of GenSci

    • Table Company Profile and Development Status of Novo Nordisk

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novo Nordisk

    • Figure Sales and Growth Rate Analysis of Novo Nordisk

    • Figure Revenue and Market Share Analysis of Novo Nordisk

    • Table Product and Service Introduction of Novo Nordisk

    • Table Company Profile and Development Status of Eli Lilly

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly

    • Figure Sales and Growth Rate Analysis of Eli Lilly

    • Figure Revenue and Market Share Analysis of Eli Lilly

    • Table Product and Service Introduction of Eli Lilly

    • Table Company Profile and Development Status of Kyowa Hakko Kirin

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Kyowa Hakko Kirin

    • Figure Sales and Growth Rate Analysis of Kyowa Hakko Kirin

    • Figure Revenue and Market Share Analysis of Kyowa Hakko Kirin

    • Table Product and Service Introduction of Kyowa Hakko Kirin

    • Table Company Profile and Development Status of Anhui Anke Biotechnology

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Anhui Anke Biotechnology

    • Figure Sales and Growth Rate Analysis of Anhui Anke Biotechnology

    • Figure Revenue and Market Share Analysis of Anhui Anke Biotechnology

    • Table Product and Service Introduction of Anhui Anke Biotechnology

    • Table Company Profile and Development Status of Pharmingen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pharmingen

    • Figure Sales and Growth Rate Analysis of Pharmingen

    • Figure Revenue and Market Share Analysis of Pharmingen

    • Table Product and Service Introduction of Pharmingen

    • Table Company Profile and Development Status of Changchun High & New Technology Industry

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Changchun High & New Technology Industry

    • Figure Sales and Growth Rate Analysis of Changchun High & New Technology Industry

    • Figure Revenue and Market Share Analysis of Changchun High & New Technology Industry

    • Table Product and Service Introduction of Changchun High & New Technology Industry

    • Table Company Profile and Development Status of Roche

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche

    • Figure Sales and Growth Rate Analysis of Roche

    • Figure Revenue and Market Share Analysis of Roche

    • Table Product and Service Introduction of Roche

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US